OFDOSE-OR SYP

OFDOSE-OR Syrup contains Ofloxacin 50 mg and Ornidazole Benzoate 125 mg, offering antibacterial and antiprotozoal action to help manage susceptible gastrointestinal and intestinal infections.

OFDOSE-OR SYRUP 

OFDOSE-OR contains  Ofloxacin 50 Mg + Ornidazole Benzoate 125 Mg  , a combination antimicrobial formulation with antibacterial and antiprotozoal properties. Ofloxacin inhibits essential bacterial enzymes required for DNA replication, while ornidazole benzoate is converted to ornidazole and acts against susceptible anaerobic microorganisms and protozoa. The combination is commonly used when gastrointestinal disturbances may involve mixed microbial pathogens. 

Indications

  • Infective diarrhoea
  • Acute dysentery
  • Amoebic intestinal infection
  • Giardial infection
  • Mixed gastrointestinal disorders
  • Anaerobic microbial conditions

Key Benefits

  • Provides complementary antimicrobial coverage
  • Helps control infection-associated loose stools
  • Targets selected bacterial pathogens
  • Acts against susceptible protozoal organisms
  • Supports recovery from intestinal infections

 

Scroll to Top